Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%
Mon, 12 Aug 14:42

GLENMARK LIFE SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%Image source: asbe/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has zoomed 7% and is presently trading at Rs 977.9.

Meanwhile, the BSE HEALTHCARE index is at 41,074.0 .

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 4.9%) and Natco Pharma (up 3.7%).

Cadila Healthcare (down 4.1%) and ASTER DM HEALTHCARE (down 3.9%) are among the top losers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 657.6 to Rs 977.9, registering a gain of Rs 320.4 (up 48.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,343.8 to 41,074.0, registering a gain of 44.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 117.4%), GRANULES INDIA (up 109.4%) and SUVEN PHARMACEUTICALS (up 108.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,845.8 (up 0.2%).

The top gainers among the BSE Sensex today are Axis Bank (up 2.0%) and JSW Steel (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,409.6 (up 0.2%). Axis Bank and Hero Motocorp are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,846.5 to 79,845.8, registering a gain of 13,999.3 points (up 21.3%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.

For the year ended March 2023, GLENMARK LIFE SCIENCES reported 11.5% increase in net profit to Rs 4,670 million compared to net profit of Rs 4,187 million during FY22. Revenue of the company grew 1.8% to Rs 21,612 million during FY23.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 26.8.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%". Click here!